INTRODUCTION
The importance of T cells in recovery from acute viral infections by the poxvirus, ectromelia (Blanden, 1974) , and the myxovirus, influenza (Ada et al., 1981) , has been firmly established. The role of T cells in viral diseases associated with persistent infection is less well defined. How T cell responses relate to the phenomena of chronic infection, latency and virus reactivation has not been clearly elucidated. The family Herpesviridae contains human and animal viruses that exhibit such clinical and subclinical phenomena during infection of natural hosts. Murid herpesvirus type 1, or murine cytomegalovirus (MCMV), a natural mouse pathogen, is an example of such a member of this family. The murine infection also has many of the clinical and subclinical manifestations found in humans who contract infection with human herpesvirus type 5 (human cytomegalovirus), making the mouse model a possible analogue of human infection.
That T cells play a role in protection from fatal infection with MCMV has been demonstrated using T cell transfer into T cell-deficient nude mice (Starr & Allison, 1977) . In non-fatal MCMV infections of normal mice. transfer of MCMV immune T cells resulted in viral clearance from spleens (Ho, 1980) . This phenomenon was class I, H-2-restricted, implying that the cells responsible for viral elimination were anti-MCMV cytotoxic T (Tc) cells (Blanden et al., 1975) , though this cannot be proven without obtaining anti-MCMV Tc clones and transferring them into infected mice. The study of the inductive requirements for such T cell responses and their regulation during primary MCMV infection are necessary prerequisites for an understanding of the latent state and how reactivation of infection may occur.
In the present studies, a method reported for human herpesvirus type 1 (HSV) (Pfizenmaier et al., 1977) was adapted to MCMV. It was demonstrated that after hind footpad (f.p.) inoculation of MCMV there was an increase in viable cell numbers within the draining popliteal lymph nodes (LN). Upon direct in vitro assay of these LN cells no anti-MCMV cytotoxic activity was detected, but anti-MCMV cytotoxicity was generated after several days in culture of the LN cells.
Industrial Gases, Alexandria, N.S.W,, Australia), after which time the cells were either subcultured immediately or kept at room temperature for up to 2 weeks prior to subculture. Conditions of subculture were the same as described for the primary cultures, except that these secondary MEF cells were always used after 4 days at 37 ~C as the source for tertiary MEF target cells in cytotoxicity assays.
Generation of antiviral effector cells.
Anti-MCMV effector cells were generated as follows. Seven days after inoculaUon of 40~tl of MCMV stock (10 ~° p.f.u.) into the hind f.p., popliteal LN were collected in Hanks" balanced salt solution (HBSS), and passed through a stainless steel mesh to produce a single-cell suspension. The LN cells were cultured in Eagle's MEM (EMEM) (cat. no. F-15, Gibco) supplemented with 10% FCS, 200 ~tg/ml streptomycin, 100 U/ml penicillin G and 125 pag/ml neomycin sulphate (antibiotics), 10 -4 M-2-mercaptoethanot (2-ME) and usually 3% (v/v) concanavalin-A-activated cell supernatant. The LN cells were cultured at 10 ~~ cells/ml in 5 ml Costar wells (cat. no. 3512) and incubated at 34 ~'C in an atmosphere containing special gas.
Remot'al o/immunoglobulin-positive (Ig +) cells.
Popliteal LN cells were depleted of Ig + cells by a one-step procedure (Parish et al., 19741 . Briefly, rosettes containing Ig + cells were obtained by reacting LN cells with sensitized sheep red blood cells coated with sheep anti-mouse immunoglobulin, The rosetted cells were separated from non-rose'tting lymphocytes by sedimentation on Ficoll-Hypaque.
Qvtotoxieity assay. For MEF target cells, 96-well flat-bottomed microtitre trays (Nunc) were seeded with tertiary MEF at 10 ~° cells/0-2 ml/well 3 days prior to assay. After 2 days in culture, each well was drained and the cells were infected with 25/al vol. of MCMV stock in DMEM at 37 ~C in special gas mixture, providing a multiplicity of infection (m.o.i.lof5 p.f.u./cell. Subsequent to viral adsorption for I h, 6 ~tCi Na_,[~l Cr]O~ (5~Cr) (Amersham) in 150 ~tl of DMEM was added to each well. At 16 h incubation, the targets were washed twice with DMEM and 100/al of effector cells was added immediately. Triplicate cultures were set up for each dilution of effector cells and incubated for 10 h at 37 ~'C in a humidified atmosphere containing special gas. 5~ Cr release from the targets was assayed by gamma emissions, and lysis calculated using the following formula : % lysis of infected or uninfected targets = [(s~Cr counts in presence of effector cells -5~Cr counts released in medium)/(~Cr counts water-lysed targets -~Cr counts released in medium)] × 100: % specific lysis = % lysis infected targets -° o lysis uninfected targets.
Preparation o/concanaralin A-actirated spleen cell supernatant (CSS). CSS was prepared using a modification of a published method (Pick & Kotkes, 1977) . Spleen cells from WEHI-3 mice were cultured in serum-free EMEM with l0 ~ M-2-ME and concanavalin-A (Pharmacia) at a final concentration of 5 ~tg/ml. All CSS preparation was carried out m the absence of FCS, Cultures were set up in 75 cm-" plastic tissue culture flasks and maintained at 37 °C in an atmosphere of special gas for 2 h The cell monolayer was then washed gently three times with warm HBSS and replenished with 30 ml fresh serum-free EMEM containing 10 -4 M-2-ME The flasks were reincubated at 37 ~C in a humidified atmosphere of special gas for 17 h. The supernatant was harvested, centrifuged to remove any cells and concentrated 10-fold on an Amicon PM-10 membrane. The concentrated CSS preparation was sterilized by filtration and stored at -20 ~C. The preparation was added to cultures at a concentration of 3 ~o (v/v).
Plaque assayJbr MCMV.
A modification of an MCMV plaque assay (Mims & Gould, 1978) was utilized. Briefly, secondary BALB/c cells were seeded into 24-well Linbro tissue culture trays (cat. no. 76-033-05, Flow Laboratories) at 10 "~' 3 cells/well/2 ml in DMEM and incubated at 37 ~C in special gas. After 24 h the medium was aspirated and 50 ~1 volumes of virus suspension in DMEM was added to the cell monolayer. Adsorption was carried out at 37 °C for 60 min after which time 2 ml of 0.5 % CM-cellulose in DMEM was added as an overlay and incubation continued for 5 days at 37 '~C in special gas. The overlay was then aspirated and a staining solution composed of 0-005% crystal violet in formol saline added for 30 min. Plaque counting was performed using a binocular microscope with 10 x magnification. All virus suspensions were sonicated for 30 s using a Branson BI2 Sonifier at 50 cycles/s prior to plaque assay, The experimental programme investigated modifications of the method reported by Pfizenmaier et al. (1977) , to determine if anti-MCMV Tc cell responses could be generated in cells from popliteal LN draining the site of MCMV inoculation if they were removed from the animal and maintained in vitro. The initial experiments were designed to determine the optimal time intervals in vivo and in vitro for anti-MCMV cytotoxic cell generation. For each in vivo and in vitro time point combination, three BALB/c female mice were inoculated into both hind f.p. with 10 ~~ p.f.u, of MCMV. The six popliteal LN were removed on day 0, 2, 4, 6 or 8 postinoculation. The LN cells were pooled, cultured for 0, 2, 4, 6 or 8 days without addition of viral antigen and then assayed for cytotoxic activity against MCMV-infected and uninfected control BALB/c MEF target cells. The assays for a particular time point in vivo coupled with variable times in vitro were performed as one experiment, e.g. the assays for day 6 in vivo with days 0, 2, 4. 6, or 8 in vitro were performed on one day.
IP
Cytotoxicity against uninfected control MEF target cells was maximal in LN cell populations harvested 4 days after viral inoculation and cultured for 2 to 6 days ( Fig. 1) . Lysis of MCMV- infected MEF targets over and above the lysis of uninfected controls required minimum intervals of 4 days in vivo post-inoculation of virus plus 2 days in vitro prior to the cytotoxicity assay (Fig. 2) . Maximum antiviral cytotoxic responses required 6 to 8 days in vivo postinoculation of MCMV plus at least 4 days of culture. The culture of LN cells from animals at day 0 and day 2 after f.p. inoculation of MCMV did not produce cytotoxic activity even after 6 to 8 days in vitro (Fig. 2) .
InJectious MCMV titres in lymph nodes on different days afier fp. inoculation
Twenty BALB/c female mice, 6 to 12 weeks of age, were inoculated into both hind f.p. with 104.6 p.f.u. MCMV. At 1 h, 3 days, 6 days or 9 days after inoculation, draining popliteal and iliac LN were removed from five animals into DMEM and stored at -70 °C until assayed for p.f.u. On the day of assay, the LN were thawed and sonicated for 30 s. The results (Table 1) showed that infectious virus could be detected in draining popliteal LN of all five mice on day 3, in l/5 LN on day 6, and in no LN on day 9. The iliac LN revealed a similar temporal profile for virus titres except that not all the iliac LN were infected on day 3.
Kinetics of anti-MCMV cytotoxic activity with different viral doses
Four groups of 15 BALB/c female mice were inoculated into both hind f.p. with 106"1, 10 s6, 104.6 or 102b p,f.u, of MCMV. On days 0, 2, 4, 6 and 8 post-inoculation the draining popliteal LN from three mice of each group were collected and single cell suspensions were prepared. The viable cells were counted, cultured for 4 days at 105.8 cells/ml and then assayed for cytotoxic activity against MCMV-infected and uninfected BALB/c MEF. The f.p. inoculations for a particular viral dose were staggered at 2-day intervals such that LN harvest, cell culture and subsequent cytotoxicity assays could be performed at the one time. The assays for the different viral doses were performed on different days for logistic reasons. Hence, the absolute values for % lysis induced by different viral doses are not comparable; only the temporal profiles can be compared.
The results (Fig. 3) showed the development of anti-MCMV cytotoxic activity in all cell pools with maximum activity at days 6 to 10 after MCMV inoculation. Cytotoxic activity did not relate to the viable cell numbers in the popliteal LN at the time of harvest (Fig. 4) . Cytotoxic activity against uninfected targets was maximal on day 4 for all viral doses (data not shown).
Because cell numbers in the popliteal LN did not correlate with the anti-MCMV cytotoxic activity generated in vitro from these cells, it was of interest to determine if the salivary gland homogenate in the stock virus preparations rather than MCMV caused the changes in LN cell numbers. Therefore, on days 0, 2, 4, 6 and 8 after bilateral hind f.p. inoculation of 104.6 p.f.u, of MCMV in 40 ~tl of diluted, infected salivary gland homogenate, both popliteal LN of three BALB/c mice were obtained, cells pooled and viable cell counts performed. All mice were injected on the same day with the subsequent LN collections staggered 2 days apart. A similar protocol was used for control mice that were injected with normal salivary gland homogenate.
Cell numbers in the popliteal LN of MCMV-infected mice increased to a maximum at 6 to 8 days after viral inoculation (Fig. 5) . No significant cellular increase occurred after normal -100 2 4 6 8 1;
Days after f.p. inoculation Fig, 3 . Kinetics of anti-MCMV cytotoxic activity with different viral doses. Effector cells were generated from six BALB/c popliteal LN removed at various days after f.p. inoculation of(a) 1026, (b) 10 +6. (c) 10 s6 or (d) 10 ~'~ p.f.u. MCMV and cultured as single-cell suspensions for 4 days. Percent specific lysis values were obtained as described in Fig. 2 . The standard errors of the mean were <4% and are not shown. salivary gland injection. A subsequent experiment which utilized a similar sampling protocol was performed on days 0, 1, 2, 5, 6, 8, 10, 14 and 19 after bilateral hind f.p. inoculation. There was an increase in cell numbers in the popliteal LN of MCMV-infected mice with a peak in cell numbers at 6 to 8 days after MCMV inoculation and a decrease to normal cell numbers by day 19 (data not shown). Similar responses to MCMV were obtained using CBA/H mice (data not shown). MCMV-infected Uninfected 10 ~~ 48-5 ± 2-6 14-5 _+ 0.7 10 *6 41.9 ± 3.0 5.5 ± 0-1 102.6 39"8 ± 2'4 6"4 + 0"4 * Effector cells were generated from three groups of six BALB/c popliteal LN removed 7 days after f.p. inoculation of 10 ~ ~, 10 ~'6 or 1026 p.f.u. MCMV and cultured as single-cell suspensions for 4 days.
t The of lysis values are the means _+ standard errors of the mean of three replicates obtained by addition onto targets of a 1/36 aliquot of cultured cells from six BALB/c popliteal LN.
The data in Fig. 3 suggested that viral doses from 10 2.6 p.f.u, up to 106'1 p.f.u, stimulated anti-MCMV cytotoxic responses provided that 6 to 10 days elapsed between viral inoculation and LN cell harvest followed by 4 days in culture. On this basis, 7 days post-inoculation in vivo and 4 days in vitro were selected as the standard interval for further studies. An example of such an experiment using different viral doses is shown in Table 2 . Viral doses of 102.6 or 10 `*.6 p.f.u. were then used in further experiments using this protocol as described in this and the accompanying paper (Sinickas et al., 1985) .
Direct lymph node assay
Tests were conducted to ascertain if anti-MCMV cytotoxic activity could be detected in draining popliteal LN of MCMV-infected mice without the 4 days in culture. Groups of three BALB/c mice were inoculated with 10 `*.6 p.f.u, into both hind f.p. at intervals of 2 to 5 days. On days 0, 2, 4, 6, 8, 10, 12, 17 and 19 post-inoculation, the six popliteal LN of each group were harvested and a 1/12 aliquot of each group's pooled LN cells was assayed for cytotoxic activity on MCMV-infected and uninfected BALB/c MEF targets. Positive control anti-MCMV cytotoxic cells (to ascertain MCMV-infected MEF target sensitivity to lysis) were obtained as t Popliteal LN cells were obtained from three BALB/c mice infected 7 days previously with 10 4.8 p.f.u, of MCMV and assayed directly.
:~ LN cells obtained as in t above were treated as described in Methods to remove Ig + cells and assayed directly. § The positive control effector cells were obtained as in ~ above, but were cultured for an additional 4 days.
described above by harvesting LN on day 7 post-inoculation of MCMV, pooling LN cells and culturing for 4 days.
To test the possibility that infected B cells in the LN cell pool were acting as unlabelled competitor targets in the cytotoxicity assay, a cell suspension was prepared from another group of six LN 7 days after MCMV inoculation and the cell population was depleted of Ig + cells prior to cytotoxic assay of a 1/12 aliquot of the remaining cells. Anti-MCMV cytotoxicity was not detected by direct assay of popliteal LN cell pools at any time post-infection (data not shown). The removal of Ig + cells from the day 7 cell pool did not unmask the presence of cytotoxic cells (Table 3) .
DISCUSSION
This paper describes experimental procedures leading to the generation of murine cytotoxic cells that lyse MCMV-infected MEF target cells. The system chosen for study was similar to that described for HSV (Pfizenmaier et al., 1977) and utilized bilateral hind f,p. inoculation of salivary gland MCMV, and harvest of draining popliteal LN followed by culture of single-cell suspensions. This and the accompanying paper (Sinickas et al., 1985) report the detailed characterization of the individual steps of the experimental protocol in order to study the kinetics, specificity and other relevant parameters of the cytotoxic response. As with HSV, the expression of cytotoxic potential against MCMV-infected MEF target cells was dependent upon a further period of time in vitro after the LN cells were removed from the mouse. Four days in vitro was consistently sufficient for this purpose.
MCMV doses from 104.6 to 1061 p.f.u, resulted in cells with anti-MCMV cytotoxic potential being present in the popliteal node from 4 to 10 days after infection with maximal levels at about 8 days. After a dose of 102.6 p.f.u., potential cytotoxicity did not appear until 6 days after infection and then persisted at maximal levels until day 10. Time points after day 10 were not studied but it would be of interest to investigate the temporal decline of cytotoxicity. MCMV was detected in the draining popliteal LN (> 103.o p.f.u.) 3 days after inoculation of 104.6 p.f.u. into the f.p., was barely detectable on day 6, and was undetectable by day 9. These results suggest that several days may be needed for MCMV to multiply in some cells of the tissues of the foot and/or of the LN, resulting in display of MCMV-dependent cell surface antigens recognized by precursors of cytotoxic lymphocytes. However, even the lowest dose of virus used (102.6 p.f.u.) was sufficient to stimulate an anti-MCMV response.
Numbers of viable cells in the draining popliteal LN increased after MCMV inoculation in the f.p. and the extent of increase was inversely related to the dose of virus.Thus, up to 10-fold increases in cell numbers were found 6 to 8 days after 102.6 or 104.6 p.f.u, of MCMV, but 106"1 p.f.u, caused only an initial increase in cell numbers that was not sustained beyond the second day after inoculation. These data imply that high doses of MCMV can interfere with processes that would lead to increases in LN cell numbers such as local cell proliferation or migration of cells into the LN via the blood or afferent lymph, but we have not evaluated this aspect further. The majority of the cells contributing to the increase in cell numbers were not directly relevant to the anti-MCMV cytotoxic response since the anti-MCMV cytotoxic potential was unrelated to the numbers of cells in the LN at time of removal for culture.
A feature of the popliteal LN cell response to MCMV infection was that from 4 days after infection significant cytotoxicity was expressed against uninfected self MEF target cells. This effect was most pronounced with LN cells taken 4 days after infection and cultured for 2 to 6 days, but was also present in uncultured LN cells taken from 4 to 8 days after infection. Autoreactivity has been reported previously as a feature of antiviral responses in vivo and in vitro and has been attributed to either cytotoxic T cells or natural killer cells (Welsh & Zinkernagel, 1977) . It is a possible complication in the interpretation of recent work involving limiting dilution to isolate clones of Tc cells responding to MCMV infection (Reddehase et al., 1984) . Since the clones were not divided and assayed on both MCMV-infected self targets and uninfected self targets, it was not determined with certainty which clones were MCMV-specific and which were autoreactive.
Although autoreactive cytotoxic activity was present in popliteal LN cells taken directly from MCMV-infected mice 4 to 8 days after infection, MCMV-specific cytotoxicity over and above autoreactivity was not directely detectable at any time up to 19 days after infection. The possibility that infected cell populations within the LN pool were acting as unlabelled competitor targets during the direct in vitro cytotoxicity assay, thereby decreasing the sensitivity of the assay for MCMV-specific cytotoxic cell detection, was tested by removal of the largest cell pool likely to be MCMV-infected (Ig + cells : Olding et al., 1975) prior to in vitro cytotoxicity testing. No anti-MCMV cytotoxic activity was unmasked using this technique on cells obtained from the draining popliteal LN on day 7 post-inoculation of 104.6 p.f.u. MCMV. This does not exclude the presence of other infected cells in the non-Ig + cell fraction, since we made no assessment of viral antigen expression within this cell pool. Nevertheless, since Ig + cells comprise approximately 50}0 of the LN cell pool, a major possible infected cell source was removed without effect.
The inability to detect direct cytotoxicity agrees with difficulties reported by other workers for MCMV (Ho, 1980) and HSV (Pfizenmaier et al., 1977) , but is in contradistinction to others who were able to detect cytotoxicity to MCMV from two lymphoid populations, spleen and cervical LN after intraperitoneal and intranasal routes of inoculation respectively (Quinnan et al., 1978 (Quinnan et al., , 1980 . The discrepancy may be accounted for by technical differences in target cell and virus preparations and manipulations of variables such as mouse ages, route of inoculation and viral dose. All of the latter are important parameters for mouse survival against MCMV infection (Mannini & Medearis, 1961) , and hence may be important factors affecting the generation of effector cells responsible for viral elimination.
In our hands, 2 to 4 days were always required for anti-MCMV cytotoxicity activity to develop in vitro in popliteal LN cells taken from the mouse 6 to 10 days after infection. The presence of CSS in the culture medium was necessary for the consistent expression of this anti-MCMV cytotoxic potential, thus raising the possibility that soluble factors which are necessary for the proliferation and/or differentiation of anti-MCMV cytotoxic cells are limiting or are insufficient to overcome some suppressor mechanism in vivo. The lack of a detectable cytotoxic response in vivo is an importanl feature of the immunobiology of herpesvirus infections, since many other virus groups have been shown to provoke primary antiviral Tc cell responses #1 vivo within 4 to 8 days : Yap & Ada, 1977 . Therefore, we have undertaken a thorough reductionist approach to the separate steps of the experimental protocol required to generate and assay anti-MCMV cytotoxic cells, beginning with the in vivo parameters studies here. Future reports will deal with the in vitro parameters, characterization of effector cells, and factors affecting the efficiency of their recognition of MCMV-infected target cells.
